SCHEMBL13664208

SCHEMBL13664208

CCCCOc1cc(C(=O)O)c(-c2c(C(=O)O)cc(OCC)c(OCCCC)c2OCCCC)c(OCCCC)c1OCCCC

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP3A4 P08684 1/20 0.45
TP53 P04637 1/20 0.44
CNR2 P34972 1/20 0.43
PTPN11 Q06124 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
S1PR3 Q99500 1/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
KDM4E B2RXH2 1/20 0.40
RXRA P19793 1/20 0.40
HNF4A P41235 1/20 0.40
PTPN1 P18031 1/20 0.40
PTPN6 P29350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11928959 0.95 TP53 (0.47) TSHRHSD17B10TP53CNR2PTPN11
SCHEMBL11929037 0.90 TSHR (0.41) TSHRHSD17B10CYP3A4TP53CNR2
SCHEMBL14364238 0.89 KDM4E (0.48) TSHRCYP3A4PTPN11KMT2AALDH1A1
SCHEMBL4299370 0.88 TSHR (0.57) TSHRHSD17B10CYP3A4TP53MEN1
SCHEMBL11929251 0.81 THRA (0.49) TSHRHSD17B10TP53CNR2PTPN11
SCHEMBL13664194 0.81 KDM4E (0.42) TSHRHSD17B10TP53CNR2ALDH1A1
SCHEMBL11929031 0.79 TSHR (0.49) TSHRHSD17B10CYP3A4MEN1KMT2A
SCHEMBL8167721 0.77 PTPN11 (0.61) TSHRHSD17B10TP53PTPN11S1PR3
SCHEMBL11929032 0.77 TSHR (0.47) TSHRHSD17B10CYP3A4TP53ALDH1A1
SCHEMBL2828736 0.77 TSHR (0.75) TSHRHSD17B10CYP3A4TP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270614-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME NAGASE & CO., LTD. (JP) 2009-10-29 US disclosed
EP-1870403-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING -AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME NAGASE & COMPANY, LTD. (JP) 2007-12-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270614-A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME BCAT1, BCAT2, AADAT TSHR 3260/4885HSD17B10 1492/4885CYP3A4 3412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.